The Journal of Immunology, Vol 149, Issue 1 83-91, Copyright © 1992 by American Association of Immunologists

ARTICLES

IL-2-induced signal transduction involves the activation of nuclear NF- kappa B expression

N Arima, WA Kuziel, TA Grdina and WC Greene
Howard Hughes Medical Institute, Department of Medicine, Duke University Medical Center, Durham, NC 27710.

Using electrophoretic mobility shift assays and DNA-protein cross- linking techniques, we demonstrate that IL-2 binding to functional forms of the human IL-2R activates nuclear expression of the eukaryotic transcription factor NF-kappa B. These inductive effects of IL-2 were observed in three different cellular systems including human Jurkat T cells stably transfected with IL-2R beta cDNA, mouse pro-B BA/F3 cells stably expressing human IL-2R beta chains either alone or in combination with human or murine IL-2R alpha chains, and purified primary resting human T cells constitutively displaying small numbers of IL-2R beta molecules. IL-2 activation of nuclear NF-kappa B expression is regulated in part at a post-translational level, involving the rapid translocation of both the 50- and 65-kDa subunits of NF-kappa B from the cytoplasm to the nucleus. However, IL-2 induction also produced an increase in mRNA for NF-kappa B p105, indicating an additional pretranslational component of regulation. In contrast, IL-2 exerts only minor effects on NF-kappa B p65 mRNA expression. IL-2 induction of NF-kappa B through the IL-2R beta subunit was both correlated with activation of the endogenous IL-2R alpha gene and critically dependent upon the presence of a serine-rich cytoplasmic domain within IL-2R beta (amino acid residues 267-312). This domain has previously been shown to be essential for IL-2-induced cell growth and may correspond to a binding site for an IL-2R beta-associated tyrosine kinase. Together, these findings suggest that NF-kappa B may play an important role as one intracellular second messenger relaying signals from the plasma membrane to cell nucleus that leads to IL-2-induced activation and growth.

This article has been cited by other articles:

				D. Artis, K. Speirs, K. Joyce, M. Goldschmidt, J. Caamano, C. A. Hunter, and P. Scott NF-{kappa}B1 Is Required for Optimal CD4+ Th1 Cell Development and Resistance to Leishmania major J. Immunol., February 15, 2003; 170(4): 1995 - 2003. [Abstract] [Full Text] [PDF]

				A. Lauder, A. Castellanos, and K. Weston c-myb Transcription Is Activated by Protein Kinase B (PKB) following Interleukin 2 Stimulation of T Cells and Is Required for PKB-Mediated Protection from Apoptosis Mol. Cell. Biol., September 1, 2001; 21(17): 5797 - 5805. [Abstract] [Full Text] [PDF]

				J. Zhang, I. Scordi, M. J. Smyth, and M. G. Lichtenheld Interleukin 2 Receptor Signaling Regulates the Perforin Gene through Signal Transducer and Activator of Transcription (Stat)5 Activation of Two Enhancers J. Exp. Med., November 1, 1999; 190(9): 1297 - 1308. [Abstract] [Full Text] [PDF]

				V. Kolenko, T. Bloom, P. Rayman, R. Bukowski, E. Hsi, and J. Finke Inhibition of NF-{kappa}B Activity in Human T Lymphocytes Induces Caspase-Dependent Apoptosis Without Detectable Activation of Caspase-1 and -3 J. Immunol., July 15, 1999; 163(2): 590 - 598. [Abstract] [Full Text] [PDF]

				M. Iacobelli, F. Rohwer, P. Shanahan, J. A. Quiroz, and K. L. McGuire IL-2-Mediated Cell Cycle Progression and Inhibition of Apoptosis Does Not Require NF-{kappa}B or Activating Protein-1 Activation in Primary Human T Cells J. Immunol., March 15, 1999; 162(6): 3308 - 3315. [Abstract] [Full Text] [PDF]

				Y. Iwanaga, T. Tsukahara, T. Ohashi, Y. Tanaka, M. Arai, M. Nakamura, K. Ohtani, Y. Koya, M. Kannagi, N. Yamamoto, et al. Human T-Cell Leukemia Virus Type 1 Tax Protein Abrogates Interleukin-2 Dependence in a Mouse T-Cell Line J. Virol., February 1, 1999; 73(2): 1271 - 1277. [Abstract] [Full Text]

				W. Ling, P. Rayman, R. Uzzo, P. Clark, H. J. Kim, R. Tubbs, A. Novick, R. Bukowski, T. Hamilton, and J. Finke Impaired Activation of NFkappa B in T Cells From a Subset of Renal Cell Carcinoma Patients Is Mediated by Inhibition of Phosphorylation and Degradation of the Inhibitor, Ikappa Balpha Blood, August 15, 1998; 92(4): 1334 - 1341. [Abstract] [Full Text] [PDF]

				M. R. Boothby, A. L. Mora, D. C. Scherer, J. A. Brockman, and D. W. Ballard Perturbation of the T Lymphocyte Lineage In Transgenic Mice Expressing a Constitutive Repressor of Nuclear Factor (NF)-{kappa}B J. Exp. Med., June 2, 1997; 185(11): 1897 - 1907. [Abstract] [Full Text] [PDF]

				C. R. Toth, R. F. Hostutler, A. S.:Jr. Baldwin, and T. P. Bender Members of the Nuclear Factor kappaB Family Transactivate the Murine c-myb Gene J. Biol. Chem., March 31, 1995; 270(13): 7661 - 7671. [Abstract] [Full Text] [PDF]

				S. Sun, P. Ganchi, D. Ballard, and W. Greene NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway Science, March 26, 1993; 259(5103): 1912 - 1915. [Abstract] [PDF]